NCT04079452View on ClinicalTrials.gov

Doravirine Concentrations and Antiviral Activity in Cerebrospinal Fluid in HIV-1 Infected Individuals

PHASE3CompletedINTERVENTIONAL
Enrollment

15

Participants

Timeline

Start Date

February 18, 2020

Primary Completion Date

August 31, 2020

Study Completion Date

August 31, 2020

Conditions
HIV-1-infection
Interventions
DRUG

Doravirine

Doravirine 100 mg tablet

DRUG

Descovy

Tenofovir alafenamide 25 mg / emtricitabine 200 mg tablet

Trial Locations (1)

08907

Hospital Universitari de Bellvitge, L'Hospitalet de Llobregat

All Listed Sponsors
collaborator

Institut d'Investigació Biomèdica de Bellvitge

OTHER

collaborator

Hospital Universitari de Bellvitge

OTHER

lead

Fundación FLS de Lucha Contra el Sida, las Enfermedades Infecciosas y la Promoción de la Salud y la Ciencia

OTHER

NCT04079452 - Doravirine Concentrations and Antiviral Activity in Cerebrospinal Fluid in HIV-1 Infected Individuals | Biotech Hunter | Biotech Hunter